Hydrocortisone Market - Forecast(2024 - 2030)

Report Code: CMR 0992 Report Format: PDF + Excel
This report gives an unequivocal investigation of the Hydrocortisone industry worldwide. It clarifies what are Hydrocortisone showcasing techniques of leading organizations and their costs. It enables you to ascertain diverse Hydrocortisone market forecast and also challenges for the coming years.

What is Hydrocortisone?
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. It is the pharmaceutical term used for cortisol.

Applications of Hydrocortisone:
Hydrocortisone damps down the body’s immune response and thereby reducing pain, itching and swelling. It is also used as a hormone replacement for people who don't have enough cortisol, a natural stress hormone. Hydrocortisone typically comes as an ointment, cream, solution (liquid), spray and tablet. It is used to treat conditions like adrenocortical insufficiency, adrenogenital syndrome, high blood calcium, thyroiditis, rheumatoid arthritis, dermatitis, asthma, and chronic obstructive pulmonary disease (COPD). 



Trends in Hydrocortisone Market:
  • Chronic Obstructive Pulmonary Disease (COPD) cases were registering significantly across the world. COPD was more common in men, but because of the higher risk of exposure to air pollution and increased smoking of tobacco among women in high-income countries now affects men and women equally. According to the Global Burden of Disease Study report, 251 million cases of COPD were prevalent globally in 2016. Hydrocortisone is will help in relieving symptoms, improving exercise capacity and quality of life by reducing the risk of death. This need in the more usage of hydrocortisone is one of the major drivers which is responsible for driving the global Hydrocortisone Market. 
  • A new research was done on a readily available drug that can help in preventing sepsis shock and death. Especially in low-income countries where the mortality rate exceeds 60%, sepsis is a major challenge for the doctors. A group of researchers has determined that a combination of intravenous vitamin C, corticosteroids (a steroid), and thiamine (vitamin B) will be effective in preventing organ dysfunction and reducing the number of deaths from severe sepsis and septic shock. As hydrocortisone is a corticosteroid, the usage of hydrocortisone will be significant in the new drug which will lead to many opportunities and growth of the global Hydrocortisone Market.
  • October 2, 2017: Sanofi, a French drugs industry has acquired Ablynx, a Belgian biotech company for 3.9 billion euros, which is likely to increase the growth in the global biotechnology market.

Key Players in the Hydrocortisone market:
The companies referred to in the market research report includes industry key players in the Hydrocortisone market who are AstraZeneca plc, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Actimis Pharmaceuticals, Valeant Pharmaceuticals, Almirall S.A, and Zylera Pharmaceuticals among others.

What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2023.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market. 
1. Hydrocortisone Market - Overview
1.1. Definitions and Scope
2. Hydrocortisone Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Hydrocortisone Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Hydrocortisone Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Hydrocortisone Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Hydrocortisone Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. The threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Hydrocortisone Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product lifecycle
7.4. Suppliers and distributors Market Share
8. Hydrocortisone Market – By Form (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Form Segment Analysis
8.3.1. Ointment
8.3.2. Cream
8.3.3. Solution (Liquid)
8.3.4. Spray
8.3.5. Tablet
9. Hydrocortisone Market – By Application (Market Size -$Million / $Billion)
9.1. Adrenocortical Insufficiency
9.2. Adrenogenital Syndrome
9.3. High Blood Calcium
9.3. Thyroiditis
9.3. Rheumatoid Arthritis
9.3. Dermatitis
9.3. Asthma
9.3. Chronic Obstructive Pulmonary Disease (COPD)
10. Hydrocortisone- By Geography (Market Size -$Million / $Billion)
10.1. Hydrocortisone Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. The U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Hydrocortisone- South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Hydrocortisone- Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Hydrocortisone– APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
10.8.5.8. Hong Kong  
10.8.5.9. Rest of APAC

10.9. Hydrocortisone– Middle East Segment and Africa Segment Research
10.10. Middle East & Africa Market Research (Market Size -$Million / $Billion)
10.10.1. Segment type Size and Market Size Analysis 
10.10.2. Revenue and Trend Analysis
10.10.3. Application Revenue and Trends by type of Application 
10.10.4. Company Revenue and Product Analysis
10.10.5. Middle East Segment Product type and Application Market Size
10.10.5.1. Israel 
10.10.5.2. Saudi Arabia
10.10.5.3. UAE
10.10.6. Africa Segment Analysis
10.10.6.1. South Africa
10.10.6.2. Rest of Middle East & Africa
11. Hydrocortisone Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Hydrocortisone Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Hydrocortisone Market – Key Company List by Country Premium
14. Hydrocortisone Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. AstraZeneca plc
14.3. GlaxoSmithKline plc
14.4. Merck & Co. Inc.
14.5. Pfizer Inc.
14.6. Sandoz AG (Novartis AG)
14.7. Sanofi S.A
14.8. Actimis Pharmaceuticals
14.9. Company 8
14.10. Company 9
14.11. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Hydrocortisone Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Hydrocortisone Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends